Table 4 Clinical-virological characteristics of CA and CAN patients
Characteristics | CA (n = 54) | CAN (n = 183) | p value |
|---|---|---|---|
Age, years | 28 (25, 33.25) | 29 (25, 36) | 0.2847 |
Gender, n (%) | Â | Â | 1.0000 |
 Female | 16 (29.6) | 53 (29) |  |
 Male | 38 (70.4) | 130 (71) |  |
Body mass index | 20.56 (19.16, 22.73) | 21.24 (19.42, 23.27) | 0.4804 |
HBV DNA, log 10Â IU/mL | 7.913 (6.595, 8.23) | 4.102 (2.717, 8.079) | 0.0000 |
HBV genotype, n (%) | Â | Â | 0.0043 |
 B | 29 (53.7) | 91 (49.7) |  |
 C | 18 (33.3) | 32 (17.5) |  |
 Other | 7 (13) | 60 (32.8) |  |
HBeAg status, n (%) | Â | Â | 0.0000 |
 HBeAg positive | 40 (74.1) | 68 (37.2) |  |
 HBeAg negative | 14 (25.9) | 114 (62.3 |  |
 Missing | 0 (0) | 1 (0.5) |  |
 HBsAg, IU/mL | 12,259.5 (2666.8, 50,107) | 2600 (708, 22,849) | 0.0002 |
Smoker, n (%) | Â | Â | 0.5465 |
 No | 50 (92.6) | 162 (88.5) |  |
 Yes | 4 (7.4) | 21 (11.5) |  |
Vertical transmission, n (%) | Â | Â | 1.0000 |
 No | 40 (74) | 137 (74.9) |  |
 Yes | 7 (13) | 24 (13.1) |  |
 Missing | 7 (13) | 22 (112.0) |  |
ALT, U/L | 101 (73, 161) | 28 (20, 35.2) | 0.0000 |
TBIL, mg/dL | 15.3 (11.8, 20.8) | 12.3 (9.6, 16.4) | 0.0006 |
ALB, g/L | 44.7 (41.9, 45.7) | 46.4 (44.4, 48.1) | 0.0008 |
FibroScan value, kPa | 6.3 (5.2, 10.6) | 4.8 (4.2, 5.6) | 0.0000 |